Agonist regulation of adenylate cyclase activity in neuroblastoma x glioma hybrid NG108-15 cells transfected to co-express adenylate cyclase type II and the β2-adrenoceptor: Evidence that adenylate cyclase is the limiting component for receptor-mediated stimulation of adenylate cyclase activity

Biochemical Journal

Volumn 318, Issue 3, 1996, Pages 1033-1039

  MacEwan, David J ^a   Kim, Gun Do ^a   Milligan, Graeme ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR; FORSKOLIN; GUANINE; GUANOSINE; ILOPROST; ISOPRENALINE; SECRETIN; TRITIUM;

AGONIST; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; GLIOMA; HUMAN; HUMAN CELL; HYBRID CELL; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; AMINO ACID SEQUENCE; BASE SEQUENCE; DNA PRIMERS; DNA, COMPLEMENTARY; EPHEDRINE; GLIOMA; HUMANS; HYBRID CELLS; ISOPROTERENOL; NEUROBLASTOMA; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; TRITIUM;

EID: 0029783432     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/bj3181033     Document Type: Article

References (32)

1. Stryer, L. and Bourne, H. R. (1986) Annu. Rev. Cell Biol. 2, 391-419
2. Alousi, A. A., Jasper, J. R., Insel, P. A. and Motulsky, H. J. (1991) FASEB J. 5, 2300-2303
3. Kim, G. D., Adie, E. J. and Milligan, G. (1994) Eur. J. Biochem. 219, 135-143
4. MacEwan, D. J., Kim, G. D. and Milligan, G. (1995) Mol. Pharmacol. 48, 316-325
5. Adie, E. J. and Milligan, G. (1994) Biochem. J. 303, 803-808
6. Mullaney, I. and Milligan, G. (1994) FEBS Lett. 353, 231-234
7. Feinstein, P. G., Schrader, K. A., Bakalyar, H. A., Tang, W.-J., Krupinski, J., Gilman, A. G. and Reed, R. R. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 10173-10177
8. Lustig, K. D., Conklin, B. R., Herzmark, P., Taussig, R. and Bourne, H. R. (1993) J. Biol. Chem. 268, 13900-13905
9. Gunning, P., Leavitt, J., Muscat, G., Ng, S. Y. and Kedes, L. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 4831-4835
10. Adie, E. J. and Milligan, G. (1994) Biochem. J. 300, 709-715
11. Milligan, G. (1987) Biochem. J. 245, 501-505
12. Milligan, G., Streaty, R. A., Gierschik, P., Spiegel, A. M. and Klee, W. A. (1987) J. Biol. Chem. 262, 8625-6630
13. Johnson, R. A. and Salomon, Y. (1991) Methods Enzymol. 195, 3-21
14. Kim, G. D., Carr, I. C. and Milligan, G. (1995) Biochem. J. 308, 275-281
15. Barber, R. (1989) Second Messengers Phosphoproteins 12, 59-71
16. DeBlasi, A., O'Reilly, K. and Motulsky, H. J. (1989) Trends Pharmacol. Sci. 10, 227-229
17. Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162, 156-159
18. Milligan, G. and Unson, C. G. (1989) Biochem. J. 261, 837-841
19. Milano, C. A., Allen, L. F., Rockman, H. A., Dolber, P. C., McMinn, T. R., Chien, K. R., Johnson, T. D., Bond, R. A. and Lefkowitz, R. J. (1994) Science 264, 582-586
20. Koch, W. J., Rockman, H. A., Samama, P., Hamilton, R., Bond, R. A., Milano, C. A. and Lefkowitz, R. J. (1995) Science 268, 1350-1353
21. Gaudin, C., Ishikawa, Y., Wight, D. C., Mahdavi, V., Nadal-Ginard, B., Wagner, T. E., Vatner, D. E. and Homcy, C. J. (1995) J. Clin. Invest. 95, 1676-1683
22. Pieroni, J. P., Jacobowitz, O., Chen, J. and Iyengar, R. (1993) Curr. Opin. Neurobiol. 3, 345-351
23. Taussig, R. and Gilman, A. G. (1995) J. Biol. Chem. 270, 1-4
24. Jacobowitz, O. and Iyengar, R. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 10630-10634
25. Tsu, R. C., Allen, R. A. and Wong, Y. H. (1995) Mol. Pharmacol. 47, 835-841
26. Chen, J., DeVivo, M., Dingus, J., Harry, A., Li, J., Sui, J., Carty, D. J., Blank, J. L., Exton, J. H., Stoffel, R. H., Inglese, J., Letkowitz, R. J., Logothetis, D. E., Hildebrandt, J. D. and Iyengar, R. (1995) Science 268, 1166-1169
27. Pieroni, J. P., Harry, A., Chen, J., Jacobowitz, O., Magnusson, R. P. and Iyengar, R. (1995) J. Biol. Chem. 270, 21368-21373
28. Laurenza, A., Sutkowski, E. M. and Seamon, K. B. (1989) Trends Pharmacol. Sci. 10, 442-147
29. Appel, J. M., Robbins, J. D., De Souza, E. B. and Seamon, K. B. (1992) J. Pharmacol. Exp. Ther. 263, 1415-1423
30. Graeser, D. and Neubig, R. R. (1993) Mol. Pharmacol. 43, 434-443
31. Neubig, R. R. (1994) FASEB J. 8, 939-946
32. Premont, R. T., Inglese, J. and Lefkowitz, R. J. (1995) FASEB J. 9, 175-182